Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Candel Therapeutics granted inducement stock options to one new employee to purchase 25,000 shares of common stock at an exercise price of $10.30 per share. The options vest with 25% on the first anniversary of the employee's start date, and the remaining 75% will vest in 36 equal monthly installments thereafter.
Key figures
- Exercise price
- 10.3
- Shares granted
- 25000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.